» Authors » Satoru Moriyama

Satoru Moriyama

Explore the profile of Satoru Moriyama including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 73
Citations 802
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawaguchi K, Ogura T, Kaneda S, Watanabe T, Soh J, Hashimoto K, et al.
Lung Cancer . 2024 Sep; 196:107961. PMID: 39340899
Objectives: We sought to compare the latest data on postoperative pain between robot-assisted thoracic surgery (RATS) and video-assisted thoracoscopic surgery (VATS), and to clarify the relationship between the number or...
2.
Nakanishi R, Okuda K, Yokota K, Tatematsu T, Sakane T, Oda R, et al.
Surg Today . 2022 Mar; 52(11):1582-1590. PMID: 35320417
Purpose: The limitations regarding indications for video-assisted thoracoscopic surgery lobectomy requiring complex surgery remain unclear. A prospective cohort study was conducted to elucidate the safety and feasibility of complex thoracoscopic...
3.
Watanabe T, Fukai I, Okuda K, Moriyama S, Haneda H, Kawano O, et al.
J Thorac Dis . 2019 Mar; 11(1):171-176. PMID: 30863586
Background: We herein report the usefulness of two types of talc pleurodesis for secondary pneumothorax of elderly patients with persistent air leak who have severe pulmonary emphysema. Methods: We assessed...
4.
Moriyama S, Yano M, Haneda H, Okuda K, Kawano O, Sakane T, et al.
J Thorac Dis . 2018 Sep; 10(8):5066-5072. PMID: 30233881
Background: Pure red cell aplasia (PRCA) associated with thymoma is relatively rare, and relevant reports are limited. We investigated the clinical features and outcomes of PRCA associated with thymoma in...
5.
Okuda K, Tatematsu T, Yano M, Nakamae K, Yamada T, Kasugai T, et al.
Mol Clin Oncol . 2018 Jul; 9(1):21-29. PMID: 29977535
Previous studies have reported that the expressions of specific proteins may predict the efficacy of chemotherapy agents for non-small cell lung cancer (NSCLC) patients. The present study evaluated the expression...
6.
Watanabe T, Okuda K, Murase T, Moriyama S, Haneda H, Kawano O, et al.
Oncotarget . 2018 May; 9(29):20769-20780. PMID: 29755688
Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 pathway are expected to be a novel therapy for combating future increases in numbers of malignant pleural mesothelioma (MPM) patients. However, the PD-L1...
7.
Sakane T, Murase T, Okuda K, Takino H, Masaki A, Oda R, et al.
Oncotarget . 2018 Feb; 9(6):6993-7009. PMID: 29467945
Currently, four immunohistochemical assays are registered with the US Food and Drug Administration to detect the expression of PD-L1. We investigated the PD-L1 expression in thymic carcinomas using these four...
8.
Okuda K, Yano M, Tatematsu T, Nakamae K, Yamada T, Kasugai T, et al.
Mol Clin Oncol . 2018 Feb; 8(1):73-79. PMID: 29387399
The majority of patients with completely resected stage II or IIIA non-small-cell lung cancer (NSCLC) require adjuvant chemotherapy to improve survival following surgery. In the present trial, the 2-year disease-free...
9.
Okuda K, Watanabe T, Oda R, Sakane T, Kawano O, Haneda H, et al.
J Thorac Dis . 2017 Dec; 9(11):E1013-E1017. PMID: 29268561
A 35-year-old woman with shortness of breath and cough was referred to our hospital and agreed to receive therapy for lung tumor in our hospital. Based on the findings from...
10.
Okuda K, Moriyama S, Haneda H, Kawano O, Sakane T, Oda R, et al.
J Thorac Dis . 2017 Dec; 9(9):2891-2894. PMID: 29221259
No abstract available.